Seeking Alpha

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive...

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive proof-of-concept data from its first Phase 1 clinical trial of NKTR-181 at the American Academy of Pain Management's 22nd Annual Clinical Meeting.
From other sites
Comments (1)
  • Vitor_B
    , contributor
    Comments (9) | Send Message
     
    Good, I'm long NKTR.
    21 Sep 2011, 01:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs